Sellas Life Sciences Stock Price Prediction
| SLS Stock | USD 1.22 0.02 1.61% |
Oversold Vs Overbought
53
Oversold | Overbought |
EPS Estimate Next Quarter (0.11) | EPS Estimate Current Year (0.52) | EPS Estimate Next Year (0.47) | Wall Street Target Price 5.8333 | EPS Estimate Current Quarter (0.13) |
Using Sellas Life hype-based prediction, you can estimate the value of Sellas Life Sciences from the perspective of Sellas Life response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Sellas Life to buy its stock at a price that has no basis in reality. In that case, they are not buying Sellas because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Sellas Life after-hype prediction price | USD 1.22 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sellas |
Sellas Life After-Hype Price Prediction Density Analysis
As far as predicting the price of Sellas Life at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sellas Life or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Sellas Life, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Sellas Life Estimiated After-Hype Price Volatility
In the context of predicting Sellas Life's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sellas Life's historical news coverage. Sellas Life's after-hype downside and upside margins for the prediction period are 0.06 and 4.32, respectively. We have considered Sellas Life's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Sellas Life is dangerous at this time. Analysis and calculation of next after-hype price of Sellas Life Sciences is based on 3 months time horizon.
Sellas Life Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Sellas Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sellas Life backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sellas Life, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.08 | 3.10 | 0.00 | 0.02 | 9 Events / Month | 5 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.22 | 1.22 | 0.00 |
|
Sellas Life Hype Timeline
On the 22nd of November Sellas Life Sciences is traded for 1.22. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.02. Sellas is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is at this time at -0.08%. %. The volatility of related hype on Sellas Life is about 1411.9%, with the expected price after the next announcement by competition of 1.20. The company recorded a loss per share of 0.67. Sellas Life Sciences last dividend was issued on the 8th of November 2019. The entity had 1:50 split on the 8th of November 2019. Considering the 90-day investment horizon the next expected press release will be in about 9 days. Check out Sellas Life Basic Forecasting Models to cross-verify your projections.Sellas Life Related Hype Analysis
Having access to credible news sources related to Sellas Life's direct competition is more important than ever and may enhance your ability to predict Sellas Life's future price movements. Getting to know how Sellas Life's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sellas Life may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| LYRA | Lyra Therapeutics | 0.01 | 5 per month | 0.00 | (0.13) | 8.00 | (10.00) | 41.07 | |
| HOOK | Hookipa Pharma | (0.05) | 6 per month | 0.00 | (0.33) | 4.05 | (7.24) | 15.72 | |
| CINGW | Cingulate Warrants | 0.01 | 1 per month | 0.00 | (0.03) | 34.83 | (25.20) | 92.13 | |
| SABS | SAB Biotherapeutics | (0.39) | 8 per month | 6.39 | 0.05 | 17.06 | (11.25) | 45.73 | |
| CVKD | Cadrenal Therapeutics, Common | 1.25 | 10 per month | 6.10 | 0.15 | 17.85 | (7.47) | 47.47 | |
| MNPR | Monopar Therapeutics | (2.62) | 9 per month | 7.94 | 0.13 | 15.93 | (9.50) | 653.56 | |
| SPRO | Spero Therapeutics | 0.02 | 10 per month | 0.00 | (0.12) | 3.79 | (4.58) | 14.92 | |
| CHRS | Coherus BioSciences | 0.01 | 9 per month | 4.72 | (0.02) | 7.62 | (6.94) | 26.43 |
Sellas Life Additional Predictive Modules
Most predictive techniques to examine Sellas price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sellas using various technical indicators. When you analyze Sellas charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Sellas Life Predictive Indicators
The successful prediction of Sellas Life stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Sellas Life Sciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Sellas Life based on analysis of Sellas Life hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Sellas Life's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Sellas Life's related companies. | 2023 | 2024 (projected) | Graham Number | 2.95 | 2.8 | Receivables Turnover | 4.56 | 2.3 |
Story Coverage note for Sellas Life
The number of cover stories for Sellas Life depends on current market conditions and Sellas Life's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sellas Life is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sellas Life's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Sellas Life Short Properties
Sellas Life's future price predictability will typically decrease when Sellas Life's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Sellas Life Sciences often depends not only on the future outlook of the potential Sellas Life's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sellas Life's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 27.8 M | |
| Cash And Short Term Investments | 2.5 M |
Additional Tools for Sellas Stock Analysis
When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.